Impact of Drug Transporter Studies on Drug Discovery and Development
Top Cited Papers
- 1 September 2003
- journal article
- review article
- Published by Elsevier in Pharmacological Reviews
- Vol. 55 (3) , 425-461
- https://doi.org/10.1124/pr.55.3.1
Abstract
Drug transporters are expressed in many tissues such as the intestine, liver, kidney, and brain, and play key roles in drug absorption, distribution, and excretion. The information on the functional characteristics of drug transporters provides important information to allow improvements in drug delivery or drug design by targeting specific transporter proteins. In this article we summarize the significant role played by drug transporters in drug disposition, focusing particularly on their potential use during the drug discovery and development process. The use of transporter function offers the possibility of delivering a drug to the target organ, avoiding distribution to other organs (thereby reducing the chance of toxic side effects), controlling the elimination process, and/or improving oral bioavailability. It is useful to select a lead compound that may or may not interact with transporters, depending on whether such an interaction is desirable. The expression system of transporters is an efficient tool for screening the activity of individual transport processes. The changes in pharmacokinetics due to genetic polymorphisms and drug-drug interactions involving transporters can often have a direct and adverse effect on the therapeutic safety and efficacy of many important drugs. To obtain detailed information about these interindividual differences, the contribution made by transporters to drug absorption, distribution, and excretion needs to be taken into account throughout the drug discovery and development process.Keywords
This publication has 356 references indexed in Scilit:
- Differential Gene Expression of Organic Anion Transporters in Male and Female RatsBiochemical and Biophysical Research Communications, 2002
- Functional Characterization of the Human Multidrug Transporter, ABCG2, Expressed in Insect CellsBiochemical and Biophysical Research Communications, 2001
- Initial sequencing and analysis of the human genomeNature, 2001
- Molecular Identification and Characterization of Novel Members of the Human Organic Anion Transporter (OATP) FamilyBiochemical and Biophysical Research Communications, 2000
- The Product of the ABC Half-Transporter Gene ABCG2 (BCRP/MXR/ABCP) Is Expressed in the Plasma MembraneBiochemical and Biophysical Research Communications, 2000
- FDA Evaluations Using In Vitro Metabolism to Predict and Interpret In Vivo Metabolic Drug‐Drug Interactions: Impact on LabelingThe Journal of Clinical Pharmacology, 1999
- Direct Evidence for Peptide Transporter (PepT1)-Mediated Uptake of a Nonpeptide Prodrug, ValacyclovirBiochemical and Biophysical Research Communications, 1998
- Renal secretion of xenobiotics mediated by P-glycoprotein: Importance to renal function in health and exploitation for targeted drug delivery to epithelial cysts in polycystic kidney diseaseAdvanced Drug Delivery Reviews, 1997
- Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.Journal of Clinical Investigation, 1995
- Pharmacokinetics of Temocapril and Enalapril in Patients with Various Degrees of Renal InsufficiencyClinical Pharmacokinetics, 1993